Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Net Income towards Common Stockholders (2016 - 2024)

Mimedx's Net Income towards Common Stockholders history spans 15 years, with the latest figure at $15.2 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 104.21% year-over-year to $15.2 million; the TTM value through Dec 2025 reached $15.2 million, down 63.83%, while the annual FY2025 figure was $48.6 million, 15.67% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $15.2 million at Mimedx, up from $7.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $44.8 million in Q4 2023 and bottomed at -$12.5 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is $7.1 million (2023), against an average of $4.0 million.
  • The largest YoY upside for Net Income towards Common Stockholders was 681.83% in 2022 against a maximum downside of 281.44% in 2022.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.4 million in 2021, then skyrocketed by 681.83% to $8.1 million in 2022, then soared by 451.13% to $44.8 million in 2023, then crashed by 83.41% to $7.4 million in 2024, then skyrocketed by 104.21% to $15.2 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Net Income towards Common Stockholders are $15.2 million (Q4 2025), $7.4 million (Q4 2024), and $7.9 million (Q3 2024).